Asthma and COPD Drugs Market - IL-5, IL-4/IL-13, and TSLP Inhibitors

added blog Wellness

2026-08-12 06:23:28 -

Market Overview The asthma and COPD drugs market is experiencing biologic emphasis where targeted biologics, IL-5 pathway inhibitors, and immune-specific agents enable phenotype-directed treatment and improved outcomes. The asthma and COPD drugs market is projected to exceed USD 32.4 billion through 2030, with biologic emphasis driven by efficacy evidence, patient outcomes, and treatment...

0 Comments 0 Shares 161 Views 0 Reviews